Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Total Current Liabilities (2021 - 2025)

Verrica Pharmaceuticals has reported Total Current Liabilities over the past 5 years, most recently at $16.4 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $16.4 million for Q4 2025, down 43.34% from a year ago — trailing twelve months through Dec 2025 was $16.4 million (down 43.34% YoY), and the annual figure for FY2025 was $16.4 million, down 43.34%.
  • Total Current Liabilities for Q4 2025 was $16.4 million at Verrica Pharmaceuticals, down from $28.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for VRCA hit a ceiling of $46.4 million in Q3 2021 and a floor of $2.6 million in Q1 2023.
  • Median Total Current Liabilities over the past 5 years was $25.0 million (2024), compared with a mean of $25.5 million.
  • Biggest five-year swings in Total Current Liabilities: crashed 94.1% in 2023 and later skyrocketed 632.69% in 2024.
  • Verrica Pharmaceuticals' Total Current Liabilities stood at $46.1 million in 2021, then crashed by 92.49% to $3.5 million in 2022, then surged by 392.17% to $17.0 million in 2023, then surged by 70.42% to $29.0 million in 2024, then crashed by 43.34% to $16.4 million in 2025.
  • The last three reported values for Total Current Liabilities were $16.4 million (Q4 2025), $28.9 million (Q3 2025), and $29.2 million (Q2 2025) per Business Quant data.